Innovate, Fund, Thrive - Denault, Jean-Francois; Tramoy, Philippe
69,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Broschiertes Buch

The authors present this book in two parts. In the first part, the focus is on getting ready to meet potential partners and investors and include topics such as identifying the information organizations and start-ups need, collecting and collating as well as building a compelling story.

Andere Kunden interessierten sich auch für
Produktbeschreibung
The authors present this book in two parts. In the first part, the focus is on getting ready to meet potential partners and investors and include topics such as identifying the information organizations and start-ups need, collecting and collating as well as building a compelling story.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Jean-Francois Denault has been working with entrepreneurs in life sciences as a professional consultant for over 20 years. He has worked with over 75 different clients in life sciences (including larger companies such as J&J, P&G, AbbVie, Denka Seiken, and Novo Nordisk) as well as numerous innovative start-ups. He specializes on marketing strategy, commercialization, business modeling and business development. His clients are located all over the world, and has completed projects with clients in over 25 different countries. Jean-Francois also works (and volunteers) as a coach and mentor for several programs and accelerators, such as the HEC-Montreal University, NextAI, the European Institute of Technology and Innovation as well as ConnectInnov, a life science incubator located in Tunisia. He is the author of both the ¿Handbook of Market Research for Life Sciences¿ (Winner of the Outstanding Business Reference Sources Award (2018)) and the ¿Handbook of Marketing Strategy for Life Sciences¿. Philippe Tramoy has been working in life sciences with wide-ranging responsibilities for over 20 years. He started research on a gene linked to leukemia and apoptosis. He worked 4 years for a U.S.-based contract manufacturing organisation (CMO), acquired by Rhodia, as Business Development Manager for EMEA. Later, he founded and managed a European market and business intelligence company. He is Partner for a Deep Tech fund at one of the European leaders in venture capital. He is also board member of life science companies such as Pep-Therapy, CryoCapCell, Scipio Biosciences, myBrain Technologies, and Aenitis Technologies. Philippe also participates as jury member or speaker for several programs and organisations such as MSC X-HEC Entrepreneur, iPHD launched by the French Government and Bpifrance. He is the author of market research reports on various topics (microalgae market, European contract biomanufacturing market, cytostatic compounds, Alzheimer disease, private equity ¿the business of building business¿.